Abstract
Single enantiomers of functionalised benzopyran-3-amines are widely used in the pharmaceutical industry as building blocks or intermediates in the synthesis of drugs acting as 5-hydroxytryptamine and dopamine receptor ligands, as well as inhibitors of dopamine β-monooxygenase. Several approaches for the preparation of the key benzopyran-3-amine intermediates in optically pure form are discussed, including synthesis and resolution of racemic mixtures, application of starting materials from the chiral pool, asymmetric synthesis and chromatographic techniques. Several examples of some larger scale production processes are provided, together with a discussion of the advantages and limitations of each approach.
Current Organic Chemistry
Title: Approaches to Enantiomerically Pure 3,4-Dihydro-2H-1-Benzopyran-3-Amines
Volume: 14 Issue: 6
Author(s): A. Beliaev, B. Broadbelt and D. A. Learmonth
Affiliation:
Abstract: Single enantiomers of functionalised benzopyran-3-amines are widely used in the pharmaceutical industry as building blocks or intermediates in the synthesis of drugs acting as 5-hydroxytryptamine and dopamine receptor ligands, as well as inhibitors of dopamine β-monooxygenase. Several approaches for the preparation of the key benzopyran-3-amine intermediates in optically pure form are discussed, including synthesis and resolution of racemic mixtures, application of starting materials from the chiral pool, asymmetric synthesis and chromatographic techniques. Several examples of some larger scale production processes are provided, together with a discussion of the advantages and limitations of each approach.
Export Options
About this article
Cite this article as:
Beliaev A., Broadbelt B. and Learmonth A. D., Approaches to Enantiomerically Pure 3,4-Dihydro-2H-1-Benzopyran-3-Amines, Current Organic Chemistry 2010; 14 (6) . https://dx.doi.org/10.2174/138527210790820249
DOI https://dx.doi.org/10.2174/138527210790820249 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Treatments of Opiate Dependence
Current Pharmaceutical Design Why So Few Drugs for Alzheimer’s Disease? Are Methods Failing Drugs?
Current Alzheimer Research Trough Plasma Concentrations of Mifepristone Correlate with Psychotic Symptom Reductions: A Review of Three Randomized Clinical Trials
Current Psychiatry Reviews Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo
Current Pharmaceutical Design Effect of Socio-Economic Factors on the Health Status of the Elderly
Applied Clinical Research, Clinical Trials and Regulatory Affairs Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis and Potential Use of Herbal Immunomodulators as Imminent Therapeutic Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry TrkB Receptor Agonist 7, 8 Dihydroxyflavone Triggers Profound Gender- Dependent Neuroprotection in Mice After Perinatal Hypoxia and Ischemia
CNS & Neurological Disorders - Drug Targets Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimers Disease
Current Drug Targets - CNS & Neurological Disorders Editorial (Thematic Issue: Modern Therapeutic Antibody Drug Discovery Technologies)
Current Drug Discovery Technologies Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research
Current Drug Targets Synthesis and Evaluation of N-substituted (Z)-5-(Benzo[d][1,3]dioxol-5- ylmethylene)-2-Thioxothiazolidin-4-one Derivatives and 5-Substituted- Thioxothiazolidindione Derivatives as Potent Anticonvulsant Agents
CNS & Neurological Disorders - Drug Targets ACKNOWLEDGEMENTS TO REVIEWERS
CNS & Neurological Disorders - Drug Targets Chitosan-Gold Nanocomposite for Copper Ions Detection
Current Nanoscience Mild Cognitive Impairment: At the Crossroad of Neurodegeneration and Vascular Dysfunction
Current Alzheimer Research Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Design and Development of Molecular Imaging Probes
Current Topics in Medicinal Chemistry Genetically-Modified Human Pluripotent Stem Cells: New Hopes for the Understanding and the Treatment of Neurological Diseases?
Current Gene Therapy Activation of Central Pain Pathways in Rheumatic Diseases: What We have Learned from Functional Neuroimaging Studies
Current Rheumatology Reviews MicroRNA-212-3p Attenuates Neuropathic Pain via Targeting Sodium Voltage-gated Channel Alpha Subunit 3 (NaV 1.3)
Current Neurovascular Research The Modern Spectrum of Rhabdomyolysis: Drug Toxicity Revealed by Creatine Kinase Screening
Current Drug Safety